Variant report

Variant	rs17006709
Chromosome Location	chr3:20227197-20227198
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:180)
CpG islands
(count:0)
Chromatin interactive
region (count:15)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:180 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	IRF1	chr3:20227074-20228463	K562	blood:	n/a	chr3:20228107-20228127 chr3:20227111-20227120 chr3:20228111-20228125
2	GATA1	chr3:20227061-20228485	PBDE	blood:	n/a	n/a
3	SIN3AK20	chr3:20227143-20228342	HCT-116	colon:	n/a	n/a
4	MYC	chr3:20227059-20228376	NB4	blood:	n/a	n/a
5	POLR2A	chr3:20226919-20228378	HEK293	kidney:	n/a	n/a
6	MAX	chr3:20227136-20228244	HepG2	liver:	n/a	n/a
7	POLR2A	chr3:20226876-20228329	K562	blood:	n/a	n/a
8	STAT5A	chr3:20227164-20228516	K562	blood:	n/a	n/a
9	POLR2A	chr3:20226939-20228370	K562	blood:	n/a	n/a
10	YY1	chr3:20227162-20228246	GM12878	blood:	n/a	chr3:20228186-20228195
11	HA-E2F1	chr3:20226920-20228379	MCF-7	breast:	n/a	n/a
12	MAX	chr3:20226941-20228310	HCT-116	colon:	n/a	n/a
13	TAF1	chr3:20227078-20228308	A549	lung:	n/a	n/a
14	JUND	chr3:20226909-20228407	K562	blood:	n/a	n/a
15	CREB1	chr3:20226769-20228336	K562	blood:	n/a	n/a
16	SIN3A	chr3:20226856-20228309	H1-hESC	embryonic stem cell:	n/a	n/a
17	MYC	chr3:20226908-20228412	K562	blood:	n/a	n/a
18	ETS1	chr3:20227187-20228036	A549	lung:	n/a	chr3:20227345-20227358
19	TBP	chr3:20226556-20228480	GM12878	blood:	n/a	n/a
20	POLR2A	chr3:20226756-20228348	GM12892	blood:	n/a	n/a
21	MAZ	chr3:20226780-20228348	GM12878	blood:	n/a	n/a
22	MXI1	chr3:20227020-20228203	HepG2	liver:	n/a	n/a
23	MAX	chr3:20226799-20228339	NB4	blood:	n/a	n/a
24	ELK4	chr3:20227062-20228076	Hela-S3	cervix:	n/a	n/a
25	BCLAF1	chr3:20227146-20228169	GM12878	blood:	n/a	n/a
26	TAF1	chr3:20227177-20227477	GM12878	blood:	n/a	n/a
27	MTA3	chr3:20226712-20228438	GM12878	blood:	n/a	n/a
28	NFIC	chr3:20227151-20228314	GM12878	blood:	n/a	n/a
29	MAX	chr3:20226926-20228120	ECC-1	luminal epithelium:	n/a	n/a
30	PML	chr3:20226614-20228363	K562	blood:	n/a	n/a
31	POLR2A	chr3:20226563-20228330	Raji	blood:	n/a	n/a
32	POLR2A	chr3:20227010-20227241	Hela-S3	cervix:	n/a	n/a
33	SIN3AK20	chr3:20226999-20228408	MCF-7	breast:	n/a	n/a
34	POLR2A	chr3:20226840-20229172	GM18505	blood:	n/a	n/a
35	TRIM28	chr3:20226808-20228343	K562	blood:	n/a	n/a
36	RAD21	chr3:20226976-20228537	IMR90	lung:	n/a	chr3:20228032-20228041
37	TBL1XR1	chr3:20227079-20228974	K562	blood:	n/a	n/a
38	REST	chr3:20226919-20228304	HL-60	blood:	n/a	n/a
39	HEY1	chr3:20226810-20228173	K562	blood:	n/a	n/a
40	USF2	chr3:20227150-20228145	GM12878	blood:	n/a	chr3:20227739-20227750
41	TAF1	chr3:20227101-20228243	GM12878	blood:	n/a	n/a
42	POLR2A	chr3:20226822-20229091	GM12878	blood:	n/a	n/a
43	IRF1	chr3:20227001-20228184	K562	blood:	n/a	chr3:20228107-20228127 chr3:20227111-20227120 chr3:20228111-20228125
44	SIN3A	chr3:20226852-20228395	GM12878	blood:	n/a	n/a
45	MYC	chr3:20226922-20228555	K562	blood:	n/a	n/a
46	FOXM1	chr3:20227158-20228212	GM12878	blood:	n/a	n/a
47	RELA	chr3:20226822-20228301	GM18951	blood:	n/a	n/a
48	TBL1XR1	chr3:20227127-20228172	K562	blood:	n/a	n/a
49	RELA	chr3:20226830-20228254	GM12892	blood:	n/a	n/a
50	POLR2A	chr3:20227110-20228230	GM12892	blood:	n/a	n/a

No data

(count:15 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:20053872..20056558-chr3:20225792..20227888,2	K562	blood:
2	chr3:19985145..19990136-chr3:20225418..20228312,6	K562	blood:
3	chr3:19987439..19992261-chr3:20226257..20229350,4	K562	blood:
4	chr3:20225377..20229978-chr3:20232761..20235716,5	K562	blood:
5	chr3:20188934..20192869-chr3:20226143..20228338,3	MCF-7	breast:
6	chr3:20226448..20228980-chr3:20231144..20234755,4	MCF-7	breast:
7	chr3:20225982..20227551-chr3:20349845..20352725,2	K562	blood:
8	chr3:20212661..20217850-chr3:20224065..20229766,9	K562	blood:
9	chr3:20215671..20219222-chr3:20225067..20228168,4	MCF-7	breast:
10	chr3:19991248..19993079-chr3:20225987..20227552,2	MCF-7	breast:
11	chr3:20211282..20213997-chr3:20225429..20228054,3	MCF-7	breast:
12	chr3:20079279..20082964-chr3:20226299..20229620,6	K562	blood:
13	chr3:20079527..20082964-chr3:20226742..20229620,4	K562	blood:
14	chr13:113841278..113842020-chr3:20226671..20227468,2	Hela-S3	cervix:
15	chr3:19987980..19990853-chr3:20225710..20227616,2	MCF-7	breast:

No data

Variant related genes	Relation type
SGOL1	TF binding region
ENSG00000114166	Chromatin interaction
ENSG00000229468	Chromatin interaction
ENSG00000144566	Chromatin interaction
ENSG00000129810	Chromatin interaction
ENSG00000252442	Chromatin interaction
ENSG00000126226	Chromatin interaction
ENSG00000237485	Chromatin interaction
ENSG00000163576	Chromatin interaction

Extended variants
information (count: 65 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:36)

rs_ID	r²[population]
rs10510500	0.99[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs11925947	0.87[YRI][hapmap];0.83[AFR][1000 genomes];1.00[EUR][1000 genomes]
rs11926045	1.00[TSI][hapmap];1.00[EUR][1000 genomes]
rs17006540	1.00[EUR][1000 genomes]
rs17006672	1.00[EUR][1000 genomes]
rs17006691	1.00[EUR][1000 genomes]
rs17006697	1.00[EUR][1000 genomes]
rs17006713	1.00[YRI][hapmap];1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs17006737	1.00[ASW][hapmap];1.00[MKK][hapmap];1.00[TSI][hapmap];1.00[YRI][hapmap];0.96[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs17006767	1.00[EUR][1000 genomes]
rs17006783	1.00[EUR][1000 genomes]
rs2068668	1.00[TSI][hapmap];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs28655370	0.94[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs3901613	0.83[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs4395419	1.00[EUR][1000 genomes]
rs56908553	0.83[AFR][1000 genomes];1.00[EUR][1000 genomes]
rs58969372	1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs59044146	1.00[EUR][1000 genomes]
rs60640011	1.00[EUR][1000 genomes]
rs60985112	1.00[EUR][1000 genomes]
rs61004804	1.00[EUR][1000 genomes]
rs6550356	1.00[TSI][hapmap];1.00[EUR][1000 genomes]
rs6550363	1.00[EUR][1000 genomes]
rs6550365	1.00[EUR][1000 genomes]
rs6770067	0.96[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs6770069	0.92[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs6799600	1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs6802066	1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs6803142	1.00[EUR][1000 genomes]
rs6806621	1.00[EUR][1000 genomes]
rs6807071	1.00[EUR][1000 genomes]
rs6808308	1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs6810209	1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs7616513	1.00[EUR][1000 genomes]
rs7642627	1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs7650577	1.00[EUR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:29 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	esv1833006	chr3:19562271-20389045	Enhancers Strong transcription Weak transcription Active TSS Flanking Active TSS Genic enhancers ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	30 gene(s)	inside rSNPs	diseases
2	nsv1010613	chr3:19942032-20461486	Weak transcription Active TSS Strong transcription Enhancers ZNF genes & repeats Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	28 gene(s)	inside rSNPs	diseases
3	esv1826830	chr3:19982972-20632072	Active TSS Genic enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription Strong transcription Enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	29 gene(s)	inside rSNPs	diseases
4	esv1829542	chr3:20009231-20384627	Enhancers Active TSS Weak transcription Strong transcription Bivalent Enhancer Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	21 gene(s)	inside rSNPs	diseases
5	nsv834627	chr3:20068115-20227975	Enhancers Weak transcription Active TSS Strong transcription Flanking Active TSS ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	17 gene(s)	inside rSNPs	diseases
6	nsv433359	chr3:20090908-20587572	Enhancers Flanking Active TSS Active TSS Strong transcription Weak transcription Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	19 gene(s)	inside rSNPs	diseases
7	nsv470450	chr3:20096735-20389045	Strong transcription Enhancers Genic enhancers Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	17 gene(s)	inside rSNPs	diseases
8	nsv1001006	chr3:20110743-20752628	Strong transcription Weak transcription Enhancers Genic enhancers Flanking Active TSS Active TSS ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	22 gene(s)	inside rSNPs	diseases
9	nsv536512	chr3:20110743-20752628	Enhancers ZNF genes & repeats Weak transcription Flanking Active TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	22 gene(s)	inside rSNPs	diseases
10	esv1829018	chr3:20116077-20596244	Strong transcription Enhancers Weak transcription Active TSS ZNF genes & repeats Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	19 gene(s)	inside rSNPs	diseases
11	esv1827700	chr3:20119716-20489086	Weak transcription Enhancers Strong transcription Flanking Active TSS Active TSS Genic enhancers ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	18 gene(s)	inside rSNPs	diseases
12	esv1830036	chr3:20121828-20278275	Active TSS Strong transcription Enhancers Weak transcription ZNF genes & repeats Genic enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	15 gene(s)	inside rSNPs	diseases
13	esv1830599	chr3:20121828-20375643	Strong transcription Weak transcription Enhancers Flanking Active TSS Active TSS Genic enhancers ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	16 gene(s)	inside rSNPs	diseases
14	esv1828816	chr3:20136508-20389045	Weak transcription Enhancers Strong transcription Genic enhancers Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	17 gene(s)	inside rSNPs	diseases
15	esv1832674	chr3:20152772-20605302	Strong transcription Enhancers Genic enhancers Active TSS Flanking Active TSS Weak transcription ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	19 gene(s)	inside rSNPs	diseases
16	esv1831853	chr3:20157077-20615273	Weak transcription Flanking Active TSS Strong transcription Enhancers Active TSS Genic enhancers ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	19 gene(s)	inside rSNPs	diseases
17	esv1833208	chr3:20157077-20638228	Active TSS Flanking Active TSS ZNF genes & repeats Weak transcription Strong transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	19 gene(s)	inside rSNPs	diseases
18	esv2422249	chr3:20163608-20626956	Enhancers Strong transcription Weak transcription Active TSS Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	19 gene(s)	inside rSNPs	diseases
19	esv1826144	chr3:20164282-20638228	Flanking Active TSS Enhancers Weak transcription Strong transcription Active TSS ZNF genes & repeats Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	19 gene(s)	inside rSNPs	diseases
20	nsv1013532	chr3:20172889-20305612	Weak transcription Enhancers Strong transcription Active TSS Flanking Active TSS Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	15 gene(s)	inside rSNPs	diseases
21	nsv536513	chr3:20172889-20305612	Strong transcription Flanking Active TSS Weak transcription Enhancers Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	15 gene(s)	inside rSNPs	diseases
22	esv1831289	chr3:20191506-20617984	Weak transcription Enhancers Flanking Active TSS ZNF genes & repeats Strong transcription Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	19 gene(s)	inside rSNPs	diseases
23	esv1829973	chr3:20192578-20375260	Weak transcription Active TSS Enhancers Strong transcription Flanking Active TSS Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	16 gene(s)	inside rSNPs	diseases
24	esv1829847	chr3:20196923-20638228	Active TSS Weak transcription ZNF genes & repeats Flanking Active TSS Strong transcription Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	19 gene(s)	inside rSNPs	diseases
25	nsv876597	chr3:20197364-20242143	Enhancers Active TSS Strong transcription Flanking Active TSS Weak transcription Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	15 gene(s)	inside rSNPs	diseases
26	esv1829457	chr3:20200232-20375260	Active TSS Enhancers ZNF genes & repeats Flanking Active TSS Weak transcription Strong transcription Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	15 gene(s)	inside rSNPs	diseases
27	esv1830113	chr3:20200232-20430932	Flanking Active TSS Weak transcription Enhancers Strong transcription Active TSS ZNF genes & repeats Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	17 gene(s)	inside rSNPs	diseases
28	esv3377463	chr3:20203472-20343029	Enhancers Strong transcription Flanking Active TSS Weak transcription Active TSS ZNF genes & repeats Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	15 gene(s)	inside rSNPs	diseases
29	esv3381923	chr3:20203492-20342999	Active TSS Enhancers Flanking Active TSS Strong transcription Weak transcription ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	15 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:126 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:20224600-20229000	Active TSS	GM12878-XiMat	blood
2	chr3:20225800-20227200	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
3	chr3:20225800-20228600	Active TSS	HUES64 Cell Line	embryonic stem cell
4	chr3:20225800-20228600	Active TSS	K562	blood
5	chr3:20225800-20228800	Active TSS	HMEC	breast
6	chr3:20225800-20229000	Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
7	chr3:20226000-20227200	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
8	chr3:20226000-20228600	Active TSS	H1 Cell Line	embryonic stem cell
9	chr3:20226000-20228600	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
10	chr3:20226000-20228600	Active TSS	Thymus	Thymus
11	chr3:20226000-20228800	Active TSS	NHDF-Ad	bronchial
12	chr3:20226000-20229000	Active TSS	ES-I3 Cell Line	embryonic stem cell
13	chr3:20226000-20229000	Active TSS	HUES48 Cell Line	embryonic stem cell
14	chr3:20226000-20229000	Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
15	chr3:20226200-20227200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
16	chr3:20226200-20228800	Active TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
17	chr3:20226200-20228800	Active TSS	NHEK	skin
18	chr3:20226200-20229000	Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
19	chr3:20226200-20229200	Active TSS	HUES6 Cell Line	embryonic stem cell
20	chr3:20226200-20229200	Active TSS	NHLF	lung
21	chr3:20226400-20227200	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
22	chr3:20226400-20227200	Flanking Active TSS	Muscle Satellite Cultured Cells	--
23	chr3:20226400-20227400	Flanking Active TSS	Primary B cells from cord blood	blood
24	chr3:20226400-20227400	Flanking Active TSS	Primary hematopoietic stem cells	blood
25	chr3:20226400-20227400	Flanking Active TSS	Primary T helper memory cells from peripheral blood 2	blood
26	chr3:20226400-20228200	Active TSS	HSMM	muscle
27	chr3:20226400-20228600	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
28	chr3:20226400-20228600	Active TSS	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
29	chr3:20226400-20228600	Active TSS	Foreskin Melanocyte Primary Cells skin01	Skin
30	chr3:20226400-20228800	Active TSS	Fetal Stomach	stomach
31	chr3:20226400-20229000	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
32	chr3:20226400-20229000	Active TSS	Fetal Intestine Large	intestine
33	chr3:20226400-20229200	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
34	chr3:20226600-20227400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
35	chr3:20226600-20227400	Flanking Active TSS	Brain Germinal Matrix	brain
36	chr3:20226600-20227600	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
37	chr3:20226600-20228200	Active TSS	Fetal Muscle Leg	muscle
38	chr3:20226600-20228400	Active TSS	Placenta Amnion	Placenta Amnion
39	chr3:20226600-20228600	Active TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
40	chr3:20226600-20228600	Active TSS	iPS-15b Cell Line	embryonic stem cell
41	chr3:20226600-20228600	Active TSS	iPS-18 Cell Line	embryonic stem cell
42	chr3:20226600-20228800	Active TSS	ES-WA7 Cell Line	embryonic stem cell
43	chr3:20226600-20228800	Active TSS	A549	lung
44	chr3:20226600-20229000	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
45	chr3:20226600-20229000	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
46	chr3:20226600-20229600	Active TSS	iPS-20b Cell Line	embryonic stem cell
47	chr3:20226800-20227200	Flanking Active TSS	Primary B cells from peripheral blood	blood
48	chr3:20226800-20227200	Enhancers	Brain Substantia Nigra	brain
49	chr3:20226800-20227200	Flanking Active TSS	Duodenum Smooth Muscle	Duodenum
50	chr3:20226800-20227400	Flanking Active TSS	Primary monocytes fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links